An open-label extension study assessing the safety of a novel oral T undecanoate (TU) formulation
Latest Information Update: 01 Nov 2021
At a glance
- Drugs Testosterone undecanoate (Primary)
- Indications Hypogonadism
- Focus Adverse reactions
- 01 Nov 2021 New trial record
- 13 Sep 2021 Results presented at the 116th Annual Meeting of the American Urological Association